The objective of this project is to determine if a combination of MRI and MRS can be used to separate participants with mild DAT from normal elderly controls by looking for focal neuronal loss, especially in the hippocampus. MRI will be used to examine brain focal atrophic changes in the hippocampus, and the MRS will be used to detect biochemical evidence of neuronal loss in the hippocampal region, as well as for more generalized loss in the frontal and parietal lobes. Hippocampal volume loss and shape deformation will be used to look for subtle regional changes in the contours of the hippocampus. Hippocampal body deformations will be related to changes in its internal architecture. As part of the internal analysis, the investigators will measure the gray matter in CA1 of the cornu ammons. MRS will be used to examine the frontal, parietal, and temporal lobes for regional neuronal loss by calculating N-acetylaspartate/creatine ratios. They also plan to conduct a longitudinal study to evaluate the evolution of both the morphometric and biochemical changes that occur during the course of this study. MRI and MRS hippocampal measurements will be compared to neuron and senile plaque counts performed by the Neuropathology Core in patients who are autopsied during the course of this study. This comparison will be extended to regions in the frontal and parietal lobes where the neuropathology core also obtains samples study.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003991-19
Application #
6563259
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2002-01-01
Project End
2002-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
19
Fiscal Year
2002
Total Cost
$178,517
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Maxwell, Taylor J; Corcoran, Chris; Del-Aguila, Jorge L et al. (2018) Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels. Alzheimers Res Ther 10:86
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Brainstorm Consortium (see original citation for additional authors) (2018) Analysis of shared heritability in common disorders of the brain. Science 360:
Kinnunen, Kirsi M; Cash, David M; Poole, Teresa et al. (2018) Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement 14:43-53
Ibanez, Laura; Dube, Umber; Davis, Albert A et al. (2018) Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease. Front Neurosci 12:230
Schultz, Stephanie A; Gordon, Brian A; Mishra, Shruti et al. (2018) Widespread distribution of tauopathy in preclinical Alzheimer's disease. Neurobiol Aging 72:177-185
Broce, Iris; Karch, Celeste M; Wen, Natalie et al. (2018) Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med 15:e1002504
Javaherian, Kavon; Newman, Brianne M; Weng, Hua et al. (2018) Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease. Alzheimer Dis Assoc Disord :
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Liao, Fan; Li, Aimin; Xiong, Monica et al. (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest 128:2144-2155

Showing the most recent 10 out of 911 publications